Home/Newsroom/Communicable diseases & vaccines

Infectious diseases & vaccines

Communicable diseases & vaccines
European Commission Approves Expanded Use of HIV-1 Therapy
EDURANT® (rilpivirine) in Younger Pediatric Patients
October 28, 2024
Belgium
Read more
Communicable diseases & vaccines
Janssen and Global Partners to Discontinue Phase 3 Mosaico HIV Vaccine Clinical Trial
January 18, 2023
Read more
Communicable diseases & vaccines
Janssen Enters into Agreement with Sanofi to Advance Potential First-In-Class Vaccine Program
October 3, 2023
United States
Read more
Communicable diseases & vaccines
U.S. FDA Approves EDURANT® PED (rilpivirine) for Certain Pediatric Patients Living with HIV-1
March 19, 2024
United States
Read more
Communicable diseases & vaccines
World Health Organization Updated Emergency Use Listing Recommends Johnson & Johnson COVID-19 Vaccine for Booster Use
April 6, 2022
United States
Read more